Antidepressant Decision Aid for Major Depressive Disorder Patients

Antidepressant Decision Aid for Major Depressive Disorder Patients

The purpose of this study is to determine whether Antidepressant Decision Aid for Major Depressive Disorder is feasible and effective in involving patients in the decision-making process when initiating pharmacotherapy.

To examine the ability of the patient decision aid to enhance shared decision making and preparedness to make decisions pertaining to antidepressant therapy. The research team has systematically developed an Antidepressant Decision Aid for Major depressive disorder patients (ADAM) according to the International Patient Decision Aids Standards (IPDAS) and the Ottawa Decision Support Framework. This is a posttest-only study with nonequivalent groups to evaluate the effect of the antidepressant decision aid on patient and physician perception of shared decision making as well as patient preparedness for making pharmacotherapeutic decisions compared usual care.

Inclusion Criteria:

• Diagnosed with Major Depressive Disorder (MDD)
• No psychotic symptoms
• Based on psychiatrist's clinical judgement currently in need for antidepressant treatment.
• Functional English literacy and language skills (to use the decision aid and fill out the questionnaires)
• Provides consent

Exclusion Criteria:

• Psychosis
• Communication barriers (visual impairment, language barrier)